Cerebral thrombosis in patients with β-thalassemia: A systematic review

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 3, 2012, Pages 212-217

  Haghpanah, Sezaneh ^a   Karimi, Mehran ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

thalassemia; cerebral; thrombosis

Indexed keywords

PLASMINOGEN; PROTEIN C; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; BETA THALASSEMIA; BLOOD TRANSFUSION; BRAIN DAMAGE; CARDIOMYOPATHY; DIABETES MELLITUS; HIGH RISK POPULATION; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPLENECTOMY; SYSTEMATIC REVIEW; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR; THROMBOCYTOSIS;

ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; BRAIN; CHILD; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MAGNETIC RESONANCE IMAGING; MALE; PROTEIN C; PROTEIN S; RISK FACTORS; SPLENECTOMY;

EID: 84859421189     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283502975     Document Type: Review

References (62)

1. Karimi M, Yavarian M, Afrasiabi A, Dehbozorgian J, Rachmilewitz E. Prevalence of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency in Iranian Jews. Arch Med Res 2008; 39:212-214. (Pubitemid 350299616)
2. Wong V, Yu YL, Liang RH, Tso WK, Li AM, Chan TK. Cerebral thrombosis in beta-thalassemia/hemoglobin E disease. Stroke 1990; 21:812-816.
3. Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006; 37:12-20. (Pubitemid 44062361)
4. Taher A, Mehio G, Isma'eel H, Cappellini MD. Stroke in thalassemia: a dilemma. Am J Hematol 2008; 83:343. (Pubitemid 351458020)
5. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99:36-43.
6. Cappellini MD, Grespi E, Cassinerio E, Bignamini D, Fiorelli G. Coagulation and splenectomy: an overview. Ann N Y Acad Sci 2005; 1054:317-324. (Pubitemid 43031039)
7. Panigrahi I, Agarwal S. Thromboembolic complications in betathalassemia: beyond the horizon. Thromb Res 2007; 120:783-789. (Pubitemid 47422335)
8. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, et al. Survival and causes of death in thalassaemia major. Lancet 1989; 2:27-30. (Pubitemid 19158169)
9. Borgna Pignatti C, Carnelli V, Caruso V, Dore F, De Mattia D, Di Palma A, et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 1998; 99:76-79. (Pubitemid 28119099)
10. Taher A, Isma'eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, et al. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost 2006; 96:488-491. (Pubitemid 44560684)
11. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000; 111:467-473. (Pubitemid 32009338)
12. Shenkman B. Thrombotic complications in thalassemic patients: contribution of red blood cells and platelets. Thromb Haemost 2008; 100:735.
13. Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from betathalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 1993; 44:63-65. (Pubitemid 23245064)
14. Eldor A, Maclouf J, Lellouche F, Ben-Yashar V, Barenholz Y, Durst R, et al. A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major. Southeast Asian J Trop Med Public Health 1993; 24 (Suppl 1):92-95.
15. Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K. Protein C and protein S deficiency in thalassemic patients. Southeast Asian J Trop Med Public Health 1992; 23 (Suppl 2):65-73.
16. Visudhiphan S, Ketsa-Ard K, Tumliang S, Piankijagum A. Significance of blood coagulation and platelet profiles in relation to pulmonary thrombosis in beta-thalassemia/Hb E. Southeast Asian J Trop Med Public Health 1994; 25:449-456.
17. Karami H, Vahidshahi K, Kosarian M, Shahmohammadi S, Dabirian M, Vafainezhad M, et al. Assessment of coagulation state and its related factors in thalassemia intermedia patients referred to Thalassemia Research Center at Booali Sina Hospital Sari/IR Iran in 2007. Pak J Biologic Sci 2010; 13:448-451.
18. Moratelli S, De Sanctis V, Gemmati D, Serino ML, Mari R, Gamberini MR, et al. Thrombotic risk in thalassemic patients. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3):915-921.
19. Naithani R, Chandra J, Narayan S, Sharma S, Singh V Thalassemia major: on the verge of bleeding or thrombosis? Hematology. 2006;11:57-61. (Pubitemid 43354963)
20. Sipahi T, Kara A, Kuybulu A, Egin Y, Akar N. Congenital thrombotic risk factors in beta-thalassemia. Clin Appl Thromb Hemost 2009; 15:581-584.
21. Musumeci S, Leonardi S, Di Dio R, Fischer A, Di Costa G. Protein C and antithrombin III in polytransfused thalassemic patients. Acta Haematol 1987; 77:30-33. (Pubitemid 17071855)
22. Angchaisuksiri P, Atichartakarn V, Aryurachai K, Archararit N, Chuncharunee S, Tiraganjana A, et al. Hemostatic and thrombotic markers in patients with hemoglobin E/beta-thalassemia disease. Am J Hematol 2007; 82:1001-1004. (Pubitemid 350004392)
23. Tripodi A, Cappellini MD, Chantarangkul V, Padovan L, Fasulo MR, Marcon A, et al. Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma. Haematologica 2009; 94:1520-1527.
24. Pierre B, Maillot F, Casset-Sedon D, Regina S, Sitbon O, Cosnay P. [Chronic pulmonary thromboembolism revealing beta-thalassemia intermedia after splenectomy]. Rev Med Interne 2006; 27:950-953. (Pubitemid 44755407)
25. Al-Hawsawi ZM, Haouimi AS, Hassan RA, Tarawah AM. Portal vein thrombosis after splenectomy for beta-thalassemia major. Saudi Med J 2004; 25:225-228. (Pubitemid 38279365)
26. Fujita F, Lyass S, Otsuka K, Giordano L, Rosenbaum DL, Khalili TM, et al. Portal vein thrombosis following splenectomy: identification of risk factors. Am Surg 2003; 69:951-956.
27. Gillis S, Cappellini MD, Goldfarb A, Ciceri L, Fiorelli G, Rachmilewitz EA. Pulmonary thromboembolism in thalassemia intermedia patients. Haematologica 1999; 84:959-960. (Pubitemid 29516934)
28. Michaeli J, Mittelman M, Grisaru D, Rachmilewitz EA. Thromboembolic complications in beta thalassemia major. Acta Haematol 1992; 87:71-74.
29. Sok J, Su W, Hopkins MA. Portal vein thrombosis following laparoscopic splenectomy for beta-thalassemia: a case study. Surg Endosc 2001; 15:1489.
30. Ciceri L, Amato M, Cappellini MD, Fiorelli G A case of pulmonary thromboembolism in thalassemia intermedia: are these patients at risk for thrombotic events? Ann Ital Med Int. 2000;15:218-220.
31. Sonakul D, Fucharoen S. Pulmonary thromboembolism in thalassemic patients. Southeast Asian J Trop Med Public Health 1992; 23 (Suppl 2): 25-28.
32. Taher A, Abou-Mourad Y, Abchee A, Zalouaa P, Shamseddine A Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication? Hemoglobin. 2002;26:107-112. (Pubitemid 34779258)
33. Zafeiriou DI, Economou M, Athanasiou-Metaxa M. Neurological complications in beta-thalassemia. Brain Dev 2006; 28:477-481.
34. Manfre L, Giarratano E, Maggio A, Banco A, Vaccaro G, Lagalla R. MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. AJR Am J Roentgenol 1999; 173:1477-1480.
35. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007; 357:1821-1828. (Pubitemid 350044802)
36. Oberoi S, Bansal D, Singh P, Marwaha RK. Stroke in a young boy with b-thalassemia intermedia secondary to moyamoya syndrome. J Pediatr Hematol Oncol 2010; 32:568-570.
37. Finkelstein Y, Yaniv I, Berant M, Zilber R, Garty BZ, Epstein O, et al. Central venous line thrombosis in children and young adults with thalassemia major. Pediatr Hematol Oncol 2004; 21:375-381. (Pubitemid 38886666)
38. Logothetis J, Constantoulakis M, Economidou J, Stefanis C, Hakas P, Augoustaki O, et al. Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology 1972; 22:294-304.
39. Paolino E, Monetti VC, Granieri E, Boldrini P. Acute cerebrovascular insults in homozygous beta-thalassaemia: a case report. J Neurol 1983; 230:37-41. (Pubitemid 13027030)
40. Dhouib N, Mellouli F, Ouederni M, Yahiaoui S, Guermazi S, Nagi S, et al. Early onset of cerebrovascular accident in a thalassemia major child. Tunis Med 2010; 88:372.
41. Karimi M, Khanlari M, Rachmilewitz EA. Cerebrovascular accident in betathalassemia major (beta-TM) and beta-thalassemia intermedia (beta-TI). Am J Hematol 2008; 83:77-79.
42. Senanayake MP, Lamabadusuriya SP. Cerebral thrombosis in betathalassaemia major. Indian J Pediatr 2001; 68:1081-1082.
43. Herguner MO, Incecik F, Altunbasak S, Sasmaz I, Leblebisatan G. Recurrent cerebral stroke in a thalassemic patient. Hematol Oncol Stem Cell Ther 2008; 1:136-138.
44. Aessopos A, Farmakis D, Karagiorga M, Rombos I, Loucopoulos D. Pseudoxanthoma elasticum lesions and cardiac complications as contributing factors for strokes in b-thalassemia patients. Stroke 1997; 28:2421-2424. (Pubitemid 28007643)
45. Singh R, Venketasubramanian N. Recurrent cerebral infarction in beta thalassaemia major. Cerebrovasc Dis 2004; 17:344-345. (Pubitemid 38621551)
46. Caksen H, Odabas D, Akbayram S, Faik Oner A, Arslan S, Cesur Y, et al. Silent stroke in a case of beta-thalassemia major associated with chronic renal failure and diabetes mellitus. J Child Neurol 2003; 18:798-800. (Pubitemid 38016576)
47. Akar N, Kemahli S, Deda G, Akar E, Yilmaz E, Uysal Z, et al. Multiple cerebral emboli in a homozygous b-thalassaemia patient due to factor V 1299 (His-Arg) 4070 A-G mutation. Turk J Haematol 2000; 17:133-136.
48. Iolascon A, Giordano P, Storelli S, Li HH, Coppola B, Piga A, et al. Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors. Haematologica 2001; 86:1112-1113. (Pubitemid 33031884)
49. Giordano P, Sabato V, Schettini F, De Mattia D, Iolascon A. Resistance to activated protein C as a risk factor of stroke in a thalassemic patient. Haematologica 1997; 82:698-700. (Pubitemid 28035564)
50. Taher AT, Musallam KM, Nasreddine W, Hourani R, Inati A, Beydoun A. Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia. J Thromb Haemost 2010; 8:54-59.
51. Karimi M, Bagheri H, Rastgu F, Rachmilewitz EA. Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with betathalassaemia intermedia. Thromb Haemost 2010; 103:989-993.
52. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, et al. Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost 2010; 8:2152-2158.
53. Metarugcheep P, Chanyawattiwongs S, Srisubat K, Pootrakul P. Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI). J Med Assoc Thai 2008; 91:889-894. (Pubitemid 351977870)
54. Hare GM, Tsui AK, McLaren AT, Ragoonanan TE, Yu J, Mazer CD. Anemia and cerebral outcomes: many questions, fewer answers. Anesth Analg 2008; 107:1356-1370.
55. Kramer AH, Zygun DA. Anemia and red blood cell transfusion in neurocritical care. Crit Care 2009; 13:R89.
56. Warnock DG, McClellan W, McClure LA, Newsome B, Campbell RC, Audhya P, et al. Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: baseline results. Kidney Int 2005; 68:1427-1431. (Pubitemid 43169887)
57. Pantoni L, Poggesi A, Inzitari D. The relation between white-matter lesions and cognition. Curr Opin Neurol 2007; 20:390-397. (Pubitemid 47051984)
58. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003; 361:2046-2048. (Pubitemid 36695049)
59. Enzinger C, Smith S, Fazekas F, Drevin G, Ropele S, Nichols T, et al. Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J Neurol 2006; 253:1064-1070. (Pubitemid 44441133)
60. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70:9-14. (Pubitemid 32096113)
61. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27:1274-1282. (Pubitemid 26286152)
62. Taher AT, Musallam KM, Nasreddine W, Beydoun A. Covert brain ischaemia in splenectomised adults with thalassemia intermedia: an emerging entity. Thromb Haemost 2010; 104:652-653.